Riskpilot← Back to searchSign inGet full accessDemedy AB
ABActiveOrg 5592104433Utförsvägen 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20191 employees
Revenue 2025
SEK 4M
+1% vs 2024
EBITDA margin
14.8%
-44% vs 2024
Equity ratio
65.2%
Financial strength
Net profit 2025
SEK 462K
-11% vs 2024
| Revenue | SEK 4M | +1% |
| EBITDA | SEK 600K | -44% |
| Net profit | SEK 462K | -11% |
| Total assets | SEK 2,5M | -38% |
| Equity | SEK 1,7M | +39% |
| Employees | 1 | — |
Legal name
Demedy AB
Org number
5592104433
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28 juni 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Distribution av medicintekniska produkter, marknadsföring, konsult samt utbildningsverksamhet samt därmed förenlig verksamhet.
Address
Utförsvägen 1
Email
marko@demedy.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 1 237 | 3 548 | 4 018 | 4 050 |
| Staff expenses | — | — | — | — | — | −841 | −223 |
| EBITDA | −1 | −16 | −18 | 110 | 952 | 1 072 | 600 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −7 | −87 | −87 |
| EBIT | −1 | −16 | −18 | 110 | 945 | 985 | 513 |
| Net financials | — | — | — | −2 | −4 | −58 | 169 |
| Profit before tax | −1 | −16 | −18 | 87 | 694 | 676 | 549 |
| Tax | −0 | −0 | −0 | −14 | −149 | −155 | −87 |
| Net profit | −1 | −16 | −18 | 73 | 545 | 521 | 462 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 499 | 496 | 116 | 909 | 1 832 | 4 106 | 2 534 |
| Equity | 49 | 33 | 52 | 125 | 669 | 1 190 | 1 651 |
| Long-term debt | 0 | 0 | 0 | 50 | 0 | — | — |
| Short-term debt | 450 | 463 | 64 | 712 | 893 | 2 395 | 229 |
| Total debt | 450 | 463 | 64 | 762 | 893 | 2 395 | 229 |
EBITDA margin
14.8%
This company
15.8%
Market median
-6% vs market
20192025
Equity ratio
65.2%
This company
38.2%
Market median
+71% vs market
20192025
Return on equity
27.9%
This company
18.4%
Market median
+52% vs market
20192025
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20192025
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
20192025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20192025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-06-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SM Chief Auditor | Chief Auditor | 2022 | — | — |
MS Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2025 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ShapeBy Sweden Holding AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ShapeBy Sweden Holding AB
Demedy AB Board members of Demedy AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Mikael Siverwall | Chief Auditor | 0 companies |
| Marko Sarcevic | Chief Executive Officer | 0 companies |
| Kosta Viktor Nikola Sarcevic | Deputy Board Member | 0 companies |
| Neha Sarcevic | Deputy Board Member | 0 companies |
| Kunal Chauhan | Chairman | 0 companies |
| Abby Jo Wiersma | Board of Directors | 0 companies |